Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Long-Term Deferred Tax (2016 - 2018)

Lifecore Biomedical, Inc. \De\ (LFCR) has 3 years of Long-Term Deferred Tax data on record, last reported at $24.6 million in Q2 2017.

  • For Q2 2017, Long-Term Deferred Tax rose 9.53% year-over-year to $24.6 million; the TTM value through May 2017 reached $24.6 million, up 9.53%, while the annual FY2017 figure was $24.6 million, 9.53% up from the prior year.
  • Long-Term Deferred Tax reached $24.6 million in Q2 2017 per LFCR's latest filing, up from $22.4 million in the prior quarter.
  • Across five years, Long-Term Deferred Tax topped out at $32.2 million in Q2 2015 and bottomed at $22.4 million in Q2 2016.
  • Average Long-Term Deferred Tax over 3 years is $26.4 million, with a median of $24.6 million recorded in 2017.
  • Peak YoY movement for Long-Term Deferred Tax: crashed 30.37% in 2016, then increased 9.53% in 2017.
  • A 3-year view of Long-Term Deferred Tax shows it stood at $32.2 million in 2015, then plummeted by 30.37% to $22.4 million in 2016, then increased by 9.53% to $24.6 million in 2017.
  • Per Business Quant database, its latest 3 readings for Long-Term Deferred Tax were $24.6 million in Q2 2017, $22.4 million in Q2 2016, and $32.2 million in Q2 2015.